Doctronic logo spinning Doctronic logo spinning
Skipping wait room...
Accessing the latest medicine...
Starting secure consult...

What Causes Hypercalcemia in Cancer Patients?

Published: May 03, 2024

Hypercalcemia, a common condition in cancer patients, can make an already difficult situation worse. This article explores the mechanisms behind this condition and why it matters.
Contents

Cancer-Linked Hypercalcemia: An Overview

Hypercalcemia affects 20-30% of cancer patients and is often linked to a poor prognosis. It is most common in cancers like breast, renal, lung, and multiple myeloma. Understanding the mechanisms is crucial for proper treatment and management.

Mechanisms Explained: The Three Main Culprits

There are three main ways cancer causes hypercalcemia: tumor secretion of parathyroid hormone-related protein (PTHrP), osteolytic metastases releasing local cytokines, and tumor production of 1,25-dihydroxyvitamin D. Each mechanism affects calcium levels differently.
Hypercalcemia is a common condition in cancer patients, associated with a poor prognosis, and caused by tumor secretion of parathyroid hormone-related protein, osteolytic metastases, and tumor production of 1,25-dihydroxyvitamin D.

Why PTHrP Matters in Hypercalcemia

PTHrP is the usual suspect in non-metastatic tumors and some lymphomas, accounting for 80% of cancer-related hypercalcemia cases. It mimics parathyroid hormone actions, causing calcium to rise. This makes it a vital marker for diagnosis and treatment response.

Frequently Asked Questions

It's a condition where calcium levels in the blood are higher than normal.

Breast, renal, lung, multiple myeloma, and squamous cell cancers.

It occurs in 20-30% of cancer cases.

PTHrP is a key marker for diagnosing and assessing treatment response.

Key Takeaways

Understanding the causes of hypercalcemia in cancer can lead to better management and treatment outcomes.
Next steps: Discuss hypercalcemia concerns with Doctronic, your AI doctor.

Related Articles

References

  1. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005; 352:373.
  2. Gastanaga VM, Schwartzberg LS, Jain RK, et al. Prevalence of hypercalcemia. Cancer Med 2016; 5:2091.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely